Talis Biomedical Corp
TLIS
Revenue
0.00
▼-73.00k▼-100.00%
3 Months ChangeAssets
72.70M
▼-9.80M▼-11.87%
3 Months ChangeLiabilities
24.07M
▼-1.74M▼-6.73%
3 Months ChangeFree Cash Flow
-6.43M
▲10.06M▲61.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 8-K
ID: 0000950170-24-107278
2024-09-06
Form 8-K
ID: 0000950170-24-104396
2024-09-03
Form 8-K
ID: 0000950170-24-102921
2024-08-23
Form 8-K
ID: 0000950170-24-100200
2024-08-19
Form 10-Q
ID: 0000950170-24-098525
2024-08-06
Form 8-K
ID: 0000950170-24-091874
2024-06-25
Form 8-K
ID: 0000950170-24-077369
2024-06-03
Form 8-K
ID: 0000950170-24-067528
2024-05-08
Form 10-Q
ID: 0000950170-24-055082
2024-05-03
Form 8-K
ID: 0000950170-24-052949